SCHOTT Pharma, a leader in pharmaceutical and biotech drug containment and delivery systems, is set to open a new manufacturing facility in North Carolina, further advancing our state’s reputation as the ‘silicon valley of pharmaceuticals‘.
Part of the SCHOTT Group, the company is most known for facilitating over 25,000 injections globally per minute.
Their new US headquarters will create at least 401 jobs with a $371 million investment in the town of Wilson. It will be the first in the U.S. to produce high-performance, pre-fillable polymer syringes, enhancing the supply of essential syringes for therapies requiring precise storage and transport.
SCHOTT Pharma will build its first U.S. facility to manufacture prefillable polymer syringes for deep-cold storage and transportation of mRNA medications. The site will also have the capability to produce glass prefillable syringes for GLP-1 therapies.https://t.co/8bKFCKOVmv pic.twitter.com/5Y6dciPfHp
— Contract Pharma (@ContractPharma) March 18, 2024
This expansion is supported by the North Carolina Department of Commerce, reflecting the state’s strategic efforts to strengthen the domestic supply chain for critical medical supplies.
“SCHOTT’s decision to select our state for this important project shows once again that North Carolina is a global leader for biotechnology and life sciences,” said Governor Cooper in a press release. “From our expertise in biomanufacturing to the proven education and training systems that are critical for workforce development, global companies recognize North Carolina’s clear advantages as a place to do business.”
The positions at the new facility will offer an average salary of $57,868, above Wilson County’s average of $52,619. The project’s funding includes a Job Development Investment Grant (JDIG) from the state, projected to boost North Carolina’s economy by $1.32 billion over 12 years. The JDIG agreement allows for up to $4,939,000 in reimbursements to SCHOTT Pharma, contingent on meeting job creation and investment targets, with a 221 percent return on investment, indicating a significant economic benefit for the state.